Cargando…
Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated Gastric Cancers
BACKGROUND/AIMS: Epstein-Barr virus-associated gastric cancers (EBVaGCs) have unique molecular and clinicopathological characteristics. The cyclic GMP-AMP synthase-stimulator of interferon genes (STING) pathway is recently recognized as the critical innate immunity against pathogens and tumors. STIN...
Autores principales: | Sun, Qi, Fu, Yao, Chen, Xiaobing, Li, Lin, Wu, Hongyan, Liu, Yixuan, Xu, Haojun, Zhou, Guoren, Fan, Xiangshan, Xia, Hongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668503/ https://www.ncbi.nlm.nih.gov/pubmed/35611665 http://dx.doi.org/10.5009/gnl210359 |
Ejemplares similares
-
Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein–Barr Virus-associated gastric carcinoma
por: Nakayama, Atsuhito, et al.
Publicado: (2019) -
Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas
por: Choi, Euno, et al.
Publicado: (2020) -
STING-IRG1 inhibits liver metastasis of colorectal cancer by regulating the polarization of tumor-associated macrophages
por: Liu, Yixuan, et al.
Publicado: (2023) -
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
por: Derks, Sarah, et al.
Publicado: (2016) -
Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
por: Re, Valli De, et al.
Publicado: (2020)